How to buy CohBar stock | $1.27

CohBar, Inc is a biotechnology business based in the US. CohBar shares (CWBR) are listed on the NASDAQ and all prices are listed in US Dollars. CohBar employs 12 staff and has a market cap (total outstanding shares value) of USD$86.2 million.

How to buy shares in CohBar

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for CohBar. Find the stock by name or ticker symbol: CWBR. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until CohBar reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At last close price of USD$1.27, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of CohBar, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of CohBar. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

CohBar share price

Use our graph to track the performance of CWBR stocks over time.

CohBar shares at a glance

• Key figures

Information last updated 2020-12-26.

Latest market close	USD$1.27
52-week range	USD$0.87 - USD$4.25
50-day moving average	USD$1.2223
200-day moving average	USD$1.3492
Wall St. target price	USD$6.38
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$-0.347

Buy CohBar shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Is it a good time to buy CohBar stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of CohBar, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

CohBar price performance over time

Historical closes compared with the close of $1.27 from 2020-12-09

1 week (2021-01-09)	N/A
1 month (2020-12-18)	-9.93%
3 months (2020-10-16)	29.72%
6 months (2020-07-17)	-25.29%

1 year (2020-01-17)	-45.02%
2 years (2019-01-18)	-65.95%
3 years (2018-01-18)	6.05
5 years (2016-01-16)	N/A

CohBar financials

Gross profit TTM	USD$0
Return on assets TTM	-38.85%
Return on equity TTM	-101.77%
Profit margin	0%
Book value	$0.328
Market capitalisation	USD$86.2 million

TTM: trailing 12 months

Shorting CohBar shares

There are currently 2.1 million CohBar shares held short by investors – that's known as CohBar's "short interest". This figure is 9.9% up from 1.9 million last month.

There are a few different ways that this level of interest in shorting CohBar shares can be evaluated.

CohBar's "short interest ratio" (SIR)

CohBar's "short interest ratio" (SIR) is the quantity of CohBar shares currently shorted divided by the average quantity of CohBar shares traded daily (recently around 485675.17564403). CohBar's SIR currently stands at 4.27. In other words for every 100,000 CohBar shares traded daily on the market, roughly 4270 shares are currently held short.

However CohBar's short interest can also be evaluated against the total number of CohBar shares, or, against the total number of tradable CohBar shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case CohBar's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 CohBar shares in existence, roughly 40 shares are currently held short) or 0.0472% of the tradable shares (for every 100,000 tradable CohBar shares, roughly 47 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against CohBar.

Find out more about how you can short CohBar stock.

CohBar share dividends

We're not expecting CohBar to pay a dividend over the next 12 months.

CohBar share price volatility

Over the last 12 months, CohBar's shares have ranged in value from as little as $0.87 up to $4.25. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while CohBar's is 2.6745. This would suggest that CohBar's shares are significantly more volatile than the average for this exchange and represent a higher risk.

CohBar overview

CohBar, Inc., a clinical stage biotechnology company, engages in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes mellitus, cancer, atherosclerosis, cardiovascular, and neurodegenerative diseases, such as Alzheimer's disease. Its lead MBT candidate is CB4211, a novel refined analog of the MOTS-c mitochondrial-derived peptide, which is in Phase Ib stage of a Phase Ia/Ib clinical trial for the treatment of nonalcoholic steatohepatitis (NASH) and obesity. The company's preclinical programs include CB5138 analogs for fibrotic diseases, CB5064 analogs for COVID-19 associated ARDS, MBT5 analogs for CXCR4-related cancer and orphan diseases, and MBT3 analogs for cancer immunotherapy. The company was founded in 2007 and is headquartered in Menlo Park, California.

Frequently asked questions

• What percentage of CohBar is owned by insiders or institutions?

  Currently 24.481% of CohBar shares are held by insiders and 12.354% by institutions.

• How many people work for CohBar?

  Latest data suggests 12 work at CohBar.

• When does the fiscal year end for CohBar?

  CohBar's fiscal year ends in December.

• Where is CohBar based?

  CohBar's address is: 1455 Adams Drive, Menlo Park, CA, United States, 94025

• What is CohBar's ISIN number?

  CohBar's international securities identification number is: US19249J1097

• What is CohBar's CUSIP number?

  CohBar's Committee on Uniform Securities Identification Procedures number is: 19249J109